More fuel for the fire: Gut microbes and toxicity to immune agonist antibodies in cancer

por Chelvanambi, Manoj, Wargo, Jennifer A.
Publicado 2021

From bugs to drugs: Bacterial 3-IAA enhances efficacy of chemotherapy in pancreatic cancer

por Seo, Y. David, Wargo, Jennifer A.
Publicado 2023

Immunotherapy resistance: the answers lie ahead – not in front – of us

por Andrews, Miles C., Wargo, Jennifer A.
Publicado 2017

Fecal microbiota transplantation as a mean of overcoming immunotherapy-resistant cancers – hype or hope?

por Baruch, Erez N., Gaglani, Tanmay, Wargo, Jennifer A.
Publicado 2021

Hallmarks of response to immune checkpoint blockade

por Cogdill, Alexandria P, Andrews, Miles C, Wargo, Jennifer A
Publicado 2017

Neoadjuvant therapy for melanoma: rationale for neoadjuvant therapy and pivotal clinical trials

por Witt, Russell G., Erstad, Derek J., Wargo, Jennifer A.
Publicado 2022

Combining checkpoint inhibitors and BRAF-targeted agents against metastatic melanoma

por Cooper, Zachary A., Frederick, Dennie T., Ahmed, Zain, Wargo, Jennifer A.
Publicado 2013

Concepts Collide: Genomic, Immune, and Microbial Influences on the Tumor Microenvironment and Response to Cancer Therapy

por Andrews, Miles C., Reuben, Alexandre, Gopalakrishnan, Vancheswaran, Wargo, Jennifer A.
Publicado 2018

Microbiome influencers of checkpoint blockade–associated toxicity

por Wang, Yinghong, Jenq, Robert R., Wargo, Jennifer A., Watowich, Stephanie S.
Publicado 2023

Monitoring and Modulating Diet and Gut Microbes to Enhance Response and Reduce Toxicity to Cancer Treatment

por Knisely, Anne, Seo, Yongwoo David, Wargo, Jennifer A., Chelvanambi, Manoj
Publicado 2023

Evidence of synergy with combined BRAF-targeted therapy and immune checkpoint blockade for metastatic melanoma

por Cooper, Zachary A, Reuben, Alexandre, Amaria, Rodabe N, Wargo, Jennifer A
Publicado 2014

Human melanoma immunotherapy using tumor antigen-specific T cells generated in humanized mice

por Hu, Zheng, Xia, Jinxing, Fan, Wei, Wargo, Jennifer, Yang, Yong-Guang
Publicado 2016

Update on use of aldesleukin for treatment of high-risk metastatic melanoma

por Amaria, Rodabe N, Reuben, Alexandre, Cooper, Zachary A, Wargo, Jennifer A
Publicado 2015

RAF Inhibitor Therapy Promotes Melanocytic Antigen Expression and Enhanced Anti-Tumor Immunity in Melanoma

por Reuben, Alexandre, Amaria, Rodabe N, Cooper, Zachary A, Wargo, Jennifer A
Publicado 2014

Combining targeted therapy and immune checkpoint inhibitors in the treatment of metastatic melanoma

por Kim, Teresa, Amaria, Rodabe N., Spencer, Christine, Reuben, Alexandre, Cooper, Zachary A., Wargo, Jennifer A.
Publicado 2014

BRAF inhibition generates a host/tumor niche that mediates therapeutic escape

por Fedorenko, Inna V., Wargo, Jennifer A., Flaherty, Keith T., Messina, Jane L., Smalley, Keiran S.M.
Publicado 2015

Linking Associations of Rare Low-Abundance Species to Their Environments by Association Networks

por Karpinets, Tatiana V., Gopalakrishnan, Vancheswaran, Wargo, Jennifer, Futreal, Andrew P., Schadt, Christopher W., Zhang, Jianhua
Publicado 2018

A PAX3/BRN2 rheostat controls the dynamics of BRAF mediated MITF regulation in MITF(high)/AXL(low) melanoma

por Smith, Michael P., Rana, Sareena, Ferguson, Jennifer, Rowling, Emily J., Flaherty, Keith T., Wargo, Jennifer A., Marais, Richard, Wellbrock, Claudia
Publicado 2018

Glioma and the gut–brain axis: opportunities and future perspectives

por Dono, Antonio, Nickles, Jack, Rodriguez-Armendariz, Ana G, McFarland, Braden C, Ajami, Nadim J, Ballester, Leomar Y, Wargo, Jennifer A, Esquenazi, Yoshua
Publicado 2022

MITF Modulates Therapeutic Resistance through EGFR Signaling

por Ji, Zhenyu, Chen, Yiyin Erin, Kumar, Raj, Taylor, Michael, Njauw, Ching-Ni Jenny, Miao, Benchun, Frederick, Dennie T., Wargo, Jennifer A., Flaherty, Keith T., Jönsson, Göran, Tsao, Hensin
Publicado 2015